Brain natriuretic peptide is a potentially useful screening tool for the detection of cardiovascular disease in patients with rheumatoid arthritis


Autoria(s): Harney, S. M. J.; Timperley, J.; Daly, C.; Harin, A.; James, T.; Brown, M. A.; Banning, A. P.; Fox, K.; Donnelly, S.; Wordsworth, B. P.
Contribuinte(s)

L. van de Putte

J. O'Flaherty

Data(s)

01/01/2006

Identificador

http://espace.library.uq.edu.au/view/UQ:81932

Idioma(s)

eng

Publicador

BMJ Publishing Group Ltd & European League Against Rheumatism

Palavras-Chave #screening #cardiovascular disease #ventricular dysfunction #end diastolic volume #brain natriuretic peptide #CX #320204 Immunogenetics #730114 Skeletal system and disorders (incl. arthritis)
Tipo

Journal Article